Skip to main content
Commentary

Our other prescription drug problem.

Lembke A, Papac J, Humphreys K. Our Other Prescription Drug Problem. N Engl J Med. 2018;378(8):693-695. doi:10.1056/NEJMp1715050.

Save
Print
March 14, 2018
Lembke A, Papac J, Humphreys K. N Engl J Med. 2018;378(8):693-695.

Unintended consequences can emerge when targeted strategies divert attention from concurrent safety concerns. This editorial recommends that lessons learned during efforts to improve opioid prescribing should be employed to reduce the potential for overprescription and misuse of benzodiazepines.

Save
Print
Cite
Citation

Lembke A, Papac J, Humphreys K. Our Other Prescription Drug Problem. N Engl J Med. 2018;378(8):693-695. doi:10.1056/NEJMp1715050.